Document ID: chunk:federal_register_of_legislation:F2019L00251:reg:9:p1
Version: federal_register_of_legislation:F2019L00251
Segment Type: reg
Provision Reference: reg 9 (pt 1/2)
Character Range: 3281–6107

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting blepharitis or death from blepharitis with the circumstances of a person's relevant service:
(1)          being a prisoner of war at the time of the clinical onset of blepharitis;
(2)          having an infection of the affected eyelid at the time of the clinical onset of blepharitis;
Note: infection of the affected eyelid is defined in the Schedule 1 - Dictionary.
(3)          having an infestation of the affected eyelid region, due to a parasite from the specified list of parasites, at the time of the clinical onset of blepharitis;
Note: specified list of parasites is defined in the Schedule 1 - Dictionary.
(4)          having a smallpox immunisation within the two weeks before the clinical onset of blepharitis;
(5)          having seborrhoeic dermatitis of the periocular region at the time of the clinical onset of blepharitis;
(6)          having rosacea of the periocular region at the time of the clinical onset of blepharitis;
(7)          having psoriasis of the periocular region at the time of the clinical onset of blepharitis;
(8)          having discoid lupus erythematosus of the periocular region at the time of the clinical onset of blepharitis;
(9)          having ocular or periocular exposure to an allergen within the 48 hours before the clinical onset of blepharitis;
Note: allergen is defined in the Schedule 1 - Dictionary.
(10)      having an irritant substance exposure to the region of the affected eye at the time of the clinical onset of blepharitis;
Note: irritant substance is defined in the Schedule 1 - Dictionary.
(11)      having mustard gas exposure to the region of the affected eye at the time of the clinical onset of blepharitis;
(12)      undergoing a course of therapeutic radiation for cancer, where the region of the affected eye was in the field of radiation, at the time of the clinical onset of blepharitis;
(13)      having a benign or malignant neoplasm affecting the affected eyelid at the time of the clinical onset of blepharitis;
(14)      having dry eye disease at the time of the clinical onset of blepharitis;
Note: dry eye disease is defined in the Schedule 1 - Dictionary.
(15)      having diabetes mellitus at the time of the clinical onset of blepharitis;
(16)      being in an immunocompromised state as specified at the time of the clinical onset of blepharitis;
Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.
(17)      taking oral isotretinoin or oral acitretin for a continuous period of at least one year before the clinical onset of blepharitis, and where treatment has ceased, the clinical onset of blepharitis has occurred within